⌘K
Loading ticker…
As of 2026-08-24, BioLife Solutions Inc. (BLFS) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 67. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.3%, relative volume 0.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
BLFS is held by 27 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $5M notional. Top 3 carry $13M.
Held by 63 ETFs · $162M across latest filings · largest weight 1.29% (SGRW).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.03% | $5M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $5M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.06% | $3M | — |
| VHTVanguard Health Care ETF | 0.02% | $3M | — |
| SMIZ | 0.60% | $2M | +0.28 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| ESML | 0.05% | $1M | — |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.06% | $1M | — |
| VTWG | 0.06% | $968K | — |
| GSSC | 0.08% | $778K | +0.03 pp |
| PSCH | 0.52% | $681K | −0.04 pp |
Showing 10 of 27 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BLFS Jan avg: 7.19% median: 4.90% win: 75% σ: 15.99% n: 4 2022-04-12 → 2026-07-31 | BLFS Feb avg: -0.61% median: -0.68% win: 25% σ: 9.44% n: 4 2022-04-12 → 2026-07-31 | BLFS Mar avg: -5.68% median: -5.66% win: 25% σ: 12.64% n: 4 2022-04-12 → 2026-07-31 | BLFS Apr avg: -8.96% median: -5.45% win: 40% σ: 19.01% n: 5 2022-04-12 → 2026-07-31 | BLFS May avg: 14.54% median: 18.22% win: 80% σ: 15.98% n: 5 2022-04-12 → 2026-07-31 | BLFS Jun avg: 1.37% median: -0.23% win: 40% σ: 7.07% n: 5 2022-04-12 → 2026-07-31 | BLFS Jul avg: 10.21% median: 10.76% win: 60% σ: 18.75% n: 5 2022-04-12 → 2026-07-31 | BLFS Aug avg: 3.64% median: 12.78% win: 75% σ: 25.55% n: 4 2022-04-12 → 2026-07-31 (current) | BLFS Sep avg: -0.13% median: -0.70% win: 50% σ: 3.99% n: 4 2022-04-12 → 2026-07-31 | BLFS Oct avg: -5.20% median: -1.58% win: 50% σ: 15.85% n: 4 2022-04-12 → 2026-07-31 | BLFS Nov avg: 6.24% median: 6.24% win: 50% σ: 16.08% n: 4 2022-04-12 → 2026-07-31 | BLFS Dec avg: 0.77% median: -7.13% win: 25% σ: 20.70% n: 4 2022-04-12 → 2026-07-31 |